S&P 500 Futures
(-0.07%) 5 304.50 points
Dow J Futures
(-0.04%) 40 128 points
Nasdaq Futures
(-0.09%) 18 487 points
Oil
(0.70%) $81.92
Gas
(-1.57%) $1.691
Gold
(0.26%) $2 218.50
Silver
(-0.62%) $24.60
Platinum
(0.06%) $910.25
USD/EUR
(0.44%) $0.927
USD/NOK
(0.69%) $10.84
USD/GBP
(0.26%) $0.793
USD/RUB
(-0.12%) $92.33

Realtime updates for Neuropathix, Inc. [NPTX]

Exchange: OTC Sector: Healthcare Industry: Biotechnology
Last Updated13 Jun 2023 @ 12:01

0.00% $ 0.000300

Live Chart Being Loaded With Signals

Commentary (13 Jun 2023 @ 12:01):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Neuropathix, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary synthetic cannabinoid derivatives platform...

Stats
Today's Volume 10 000.00
Average Volume 13 596.00
Market Cap 28 143.00
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.00750
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2022-06-06 Petkanas Dean Sell 10 000 Common Stock
2022-06-07 Petkanas Dean Sell 50 000 Common Stock
2022-06-08 Petkanas Dean Sell 21 836 Common Stock
2022-06-09 Petkanas Dean Sell 238 164 Common Stock
2022-06-13 Petkanas Dean Sell 300 000 Common Stock
INSIDER POWER
-100.00
Last 56 transactions
Buy: 20 518 991 | Sell: 5 700 000

Volume Correlation

Long: -0.12 (neutral)
Short: 0.00 (neutral)
Signal:(47.122) Neutral

Neuropathix, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Neuropathix, Inc. Correlation - Currency/Commodity

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )

Neuropathix, Inc. Financials

Annual 2021
Revenue: $183 477
Gross Profit: $0.00 (0.00 %)
EPS: $-0.0480
Q1 2022
Revenue: $207 980
Gross Profit: $207 980 (100.00 %)
EPS: $-0.0206
Q4 2021
Revenue: $151 477
Gross Profit: $0.00 (0.00 %)
EPS: $-0.00840
Q3 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.0100

Financial Reports:

No articles found.

Neuropathix, Inc.

Neuropathix, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary synthetic cannabinoid derivatives platform. It engages in the research and development of chemical entities, such as KLS-13019, KLS-13023, and KLS-13022, as well as its related molecules; and synthetic cannabidiol therapeutics through pre-clinical drug discovery and development processes for use in the disease indications of chemotherapy induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. The company was formerly known as Kannalife, Inc. and changed its name to Neuropathix, Inc. in November 2020. Neuropathix, Inc. was founded in 2010 and is based in Doylestown, Pennsylvania.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators